The legal library gives you easy access to the FTC’s case information and other official legal, policy, and guidance documents.
SkyMed International, Inc., In the Matter of
SkyMed must put in place a comprehensive information security program as part of a settlement with the FTC over allegations the company failed to take reasonable steps to secure sensitive consumer information such as health records.
Concurring Statement of Acting Chairwoman Rebecca Kelly Slaughter joined by Commissioner Rohit Chopra regarding the Revised Clayton Act Thresholds
Warning Letter to Freedman Chiropractic Center, LLC
Statement of Commissioners Noah Joshua Phillips and Christine S. Wilson Regarding the Commission's Indefinite Suspension of Early Terminations
2102001 Informal Interpretation
Digital Altitude LLC
The Federal Trade Commission alleged that the defendants operated a multi-million dollar business coaching scheme known as Digital Altitude that they deceived consumers by claiming they could earn "six figures in 90 days."
The Federal Trade Commission is sending refunds totaling nearly $4.7 million to people who lost money as a result of the scheme.
20210958: Thermo Fisher Scientific Inc.; Mesa Biotech, Inc.
Statement of Commissioner Rohit Chopra Regarding the Deception of Delivery Drivers by Amazon.com
Joint Statement of Acting Chairwoman Rebecca Kelly Slaughter and Commissioner Noah Joshua Phillips in the Matter of Amazon Flex
86 FR 7870
Zoom Video Communications, Inc., In the Matter of
Zoom Video Communications, Inc. will be required to implement a robust information security program to settle FTC allegations that the video conferencing provider engaged in a series of deceptive and unfair practices that undermined the security of its users.
Statement of Commissioner Christine S. Wilson In the Matter of Zoom Video Communications, Inc.
Dissenting Statement of Commissioner Rohit Chopra Regarding Final Approval of the Settlement with Zoom Communications, Inc.
Dissenting Statement of Commissioner Rebecca Kelly Slaughter Regarding Final Approval of the Settlement with Zoom Video Communications, Inc.
Pfizer/Mylan, In the Matter of
Pharmaceutical companies Pfizer Inc. and Mylan N.V. have agreed to divest assets and abide by other conditions to settle Federal Trade Commission charges that the proposed combination of Upjohn Inc. and Mylan N.V. will harm current or future competition in ten generic drug markets. The FTC’s complaint alleges that the proposed combination would harm current U.S. competition in seven product markets by reducing the number of existing suppliers, and that it would harm future U.S. competition in three additional product markets. The proposed consent order requires divestitures in all 10 markets.